RAPID TREND SHIFT IN RADIOLOGY TECHNOLOGY AND ACCESSIBILITY
With
Dr Mansoor Parker,
Diagnostic & Interventional Radiologist & Founding Partner,
Quantum Radiology, Sydney &
Board Member,
Australian Diagnostic Imaging Association
PEOPLE IN HEALTH CARE SEGMENT
Filmed in Sydney | October 2025
Dr Mansoor Parker obtained his medical degree from the University of Tasmania. He then completed his specialist radiology training at Nepean Hospital, Sydney with subspecialty interests in Interventional Radiology and Pain Management, Musculoskeletal, Cardiac and Abdominal Imaging. Dr Parker is a qualified specialist since 2005 and is a member of the Royal Australian and New Zealand College of Radiologists and the exclusive Australasian Musculoskeletal Imaging Group (AMSIG) as well as the Interventional Radiology Society of Australasia (IRSA).
Dr Parker has completed his Masters Training in Cardiac CT (Level B) and CT Colonography. He has also completed CT Colonography and Cardiac CT Angiography Accreditation obtaining Level 2 Society of Cardiovascular CT (CTCA), the highest level available in Australia. He sits on the board of directors of Australian Diagnostic Imaging Associated (ADIA) and is a committee member of the Medical Imaging Accreditation Scheme Advisory Committee (MIASAC) as part of the Australian Commission on Safety and Quality in Health Care.
Dr Mansoor Parker has been involved in developing CT Colonography software used on many CT machines today. Dr Parker is the founding partner of Quantum Radiology (founded in 2005) and serves in the position of the Chair of the Doctors Management Committee (DMC) at the Quantum Medscan Radiology Group
Source: Supplied
-
Taiwanese health and research delegation visit Paratus clinical trial site in Canberra
In late August 2025, a Taiwanese delegation comprising government officials from the Taiwanese FDA, various governmental groups, and physicians and researchers from across Taiwan, visited Paratus Clinical’s trial site in Canberra. Their objective was to explore both the differences and similarities between the clinical research ecosystems of Taiwan and Australia.
-
Landmark research projects tackle critical issues in emergency healthcare
For two decades, the demand for emergency department services in Australia has outpaced population growth and wait times have increased. In 2022-2023 more than 8.8 million emergency department presentations occurred nationwide.
While demand is a contributing factor, EDs are currently being impacted by various factors across the entire health system.
The Emergency Medicine Foundation (EMF) is a non-profit organisation funding innovative Australian research that improves the way people are cared for in a medical emergency. The aim of the research is to deliver better and more effective health services to save lives and money.
-
New clinical research entity first to operate across both Australia and New Zealand
Over the past 30 years, 18,000 clinical trials that have been registered in Australia, with the sector contributing $1.4 billion to Australia’s economy annually. Trials are a critical aspect of evidence-based medicine, and are essential for testing how new treatments, tests and vaccines will work. In New Zealand they contribute $146 million to the New Zealand economy.
To capitalise on this unique position and growth, a coordinated multi-site clinical research operation was missing, until now.
